BamSEC and AlphaSense Join Forces
Learn More

Lineage Cell Therapeutics, Inc.

NYSE American: LCTX    
Share price (12/20/24): $0.56    
Market cap (12/20/24): $105 million
Search in Documents
Key Exhibits
External Links

Transcripts

CY 2024
Earnings Revised 11/21/24 Lineage Cell Therapeutics, Inc., Q3 2024 Earnings Call, Nov 14, 2024 11/14/24 Earnings Revised 08/09/24 Lineage Cell Therapeutics, Inc., Q2 2024 Earnings Call, Aug 08, 2024 08/08/24 Other Revised 07/24/24 Lineage Cell Therapeutics, Inc. - Special Call 07/23/24 Earnings Revised 05/10/24 Lineage Cell Therapeutics, Inc., Q1 2024 Earnings Call, May 09, 2024 05/09/24 Earnings Revised 03/08/24 Lineage Cell Therapeutics, Inc., Q4 2023 Earnings Call, Mar 07, 2024 03/07/24
CY 2023
Earnings Revised 11/21/23 Lineage Cell Therapeutics, Inc., Q3 2023 Earnings Call, Nov 09, 2023 11/09/23 Earnings Revised 10/25/23 Lineage Cell Therapeutics, Inc., Q2 2023 Earnings Call, Aug 10, 2023 08/10/23 Earnings Revised 06/20/23 Lineage Cell Therapeutics, Inc., Q1 2023 Earnings Call, May 11, 2023 05/11/23 Earnings Revised 03/09/23 Lineage Cell Therapeutics, Inc., Q4 2022 Earnings Call, Mar 09, 2023 03/09/23
CY 2022
Earnings Revised 11/10/22 Lineage Cell Therapeutics, Inc., Q3 2022 Earnings Call, Nov 10, 2022 11/10/22 Earnings Revised 08/11/22 Lineage Cell Therapeutics, Inc., Q2 2022 Earnings Call, Aug 11, 2022 08/11/22 Earnings Revised 05/12/22 Lineage Cell Therapeutics, Inc., Q1 2022 Earnings Call, May 12, 2022 05/12/22 Earnings Revised 03/10/22 Lineage Cell Therapeutics, Inc., Q4 2021 Earnings Call, Mar 10, 2022 03/10/22
CY 2021
Other Revised 12/20/21 Lineage Cell Therapeutics, Inc. - Special Call 12/20/21 Earnings Revised 11/10/21 Lineage Cell Therapeutics, Inc., Q3 2021 Earnings Call, Nov 10, 2021 11/10/21 Earnings Revised 08/12/21 Lineage Cell Therapeutics, Inc., Q2 2021 Earnings Call, Aug 12, 2021 08/12/21 Other Revised 06/10/21 Lineage Cell Therapeutics, Inc. - Special Call 06/10/21 Earnings Revised 05/13/21 Lineage Cell Therapeutics, Inc., Q1 2021 Earnings Call, May 13, 2021 05/13/21 Earnings Revised 03/11/21 Lineage Cell Therapeutics, Inc., Q4 2020 Earnings Call, Mar 11, 2021 03/11/21 Other Revised 02/22/21 Lineage Cell Therapeutics, Inc. - Analyst/Investor Day 02/22/21
CY 2020
Other Revised 11/17/20 Lineage Cell Therapeutics, Inc. - Special Call 11/17/20 Earnings Revised 11/04/20 Lineage Cell Therapeutics, Inc., Q3 2020 Earnings Call, Nov 04, 2020 11/04/20 Earnings Revised 08/06/20 Lineage Cell Therapeutics, Inc., Q2 2020 Earnings Call, Aug 06, 2020 08/06/20 Other Revised 06/08/20 Lineage Cell Therapeutics, Inc. - Special Call 06/08/20 Other Revised 05/11/20 Lineage Cell Therapeutics, Inc. - Special Call 05/11/20 Earnings Revised 05/07/20 Lineage Cell Therapeutics, Inc., Q1 2020 Earnings Call, May 07, 2020 05/07/20 Earnings Revised 03/12/20 Lineage Cell Therapeutics, Inc., Q4 2019 Earnings Call, Mar 12, 2020 03/12/20
CY 2019
Other Revised 11/15/19 Lineage Cell Therapeutics, Inc. - Shareholder/Analyst Call 11/15/19 Earnings Revised 11/12/19 Lineage Cell Therapeutics, Inc., Q3 2019 Earnings Call, Nov 12, 2019 11/12/19 Earnings Revised 08/08/19 BioTime, Inc., Q2 2019 Earnings Call, Aug 08, 2019 08/08/19 Earnings Revised 05/09/19 BioTime, Inc., Q1 2019 Earnings Call, May 09, 2019 05/09/19 Earnings Revised 03/14/19 BioTime, Inc., Q4 2018 Earnings Call, Mar 14, 2019 03/14/19
CY 2018
Earnings Revised 11/08/18 BioTime, Inc., Q3 2018 Earnings Call, Nov 08, 2018 11/08/18 Earnings Revised 08/02/18 BioTime, Inc., Q2 2018 Earnings Call, Aug 02, 2018 08/02/18 Earnings Revised 05/10/18 BioTime, Inc., Q1 2018 Earnings Call, May 10, 2018 05/10/18 Earnings Revised 03/15/18 BioTime, Inc., Q4 2017 Earnings Call, Mar 15, 2018 03/15/18
CY 2017
Earnings Revised 11/09/17 BioTime, Inc., Q3 2017 Earnings Call, Nov 09, 2017 11/09/17 Earnings Revised 08/02/17 BioTime, Inc., Q2 2017 Earnings Call, Aug 02, 2017 08/02/17
CY 2014
Other Revised 06/07/23 Amedra Pharmaceuticals LLC, CorePharma, L.L.C., Impax Laboratories Inc., Lineage Therapeutics Inc., Tower Holdings, Inc. - M&A Call 10/09/14